LivaNova Past Earnings Performance
Past criteria checks 4/6
LivaNova has been growing earnings at an average annual rate of 38.5%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 3.3% per year. LivaNova's return on equity is 1.8%, and it has net margins of 1.9%.
Key information
38.5%
Earnings growth rate
39.7%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 3.3% |
Return on equity | 1.8% |
Net Margin | 1.9% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 12LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 03LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital
Oct 31LivaNova: Economics Should Start Making Sustained Improvements
Oct 18Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?
Oct 02LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares
Aug 21LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger
Jul 30At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?
Jul 04Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?
Jun 13LivaNova: Focus Is Paying Off
May 12These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19Revenue & Expenses Breakdown
How LivaNova makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,242 | 24 | 516 | 180 |
30 Jun 24 | 1,210 | -17 | 527 | 178 |
31 Mar 24 | 1,185 | -32 | 524 | 184 |
31 Dec 23 | 1,154 | 18 | 518 | 188 |
30 Sep 23 | 1,118 | 3 | 499 | 212 |
30 Jun 23 | 1,085 | -97 | 479 | 201 |
31 Mar 23 | 1,045 | -82 | 470 | 184 |
31 Dec 22 | 1,022 | -86 | 464 | 175 |
30 Sep 22 | 1,017 | -93 | 474 | 146 |
30 Jun 22 | 1,018 | -29 | 468 | 152 |
31 Mar 22 | 1,028 | -102 | 475 | 171 |
31 Dec 21 | 1,035 | -136 | 472 | 183 |
30 Sep 21 | 1,035 | -414 | 462 | 191 |
30 Jun 21 | 1,022 | -385 | 457 | 197 |
31 Mar 21 | 939 | -417 | 442 | 169 |
31 Dec 20 | 934 | -347 | 447 | 153 |
30 Sep 20 | 952 | -208 | 462 | 147 |
30 Jun 20 | 981 | -161 | 481 | 146 |
31 Mar 20 | 1,076 | -102 | 501 | 155 |
31 Dec 19 | 1,084 | -158 | 528 | 147 |
30 Sep 19 | 1,094 | -222 | 495 | 162 |
30 Jun 19 | 1,097 | -260 | 489 | 159 |
31 Mar 19 | 1,107 | -211 | 484 | 159 |
31 Dec 18 | 1,107 | -178 | 465 | 146 |
30 Sep 18 | 1,088 | 0 | 444 | 135 |
30 Jun 18 | 1,068 | 33 | 424 | 121 |
31 Mar 18 | 1,036 | 59 | 397 | 115 |
31 Dec 17 | 1,012 | 54 | 380 | 110 |
30 Sep 17 | 795 | 121 | 292 | 66 |
30 Jun 17 | 840 | 92 | 303 | 69 |
31 Mar 17 | 905 | 55 | 329 | 71 |
31 Dec 16 | 965 | 2 | 355 | 82 |
31 Dec 15 | 545 | -22 | 221 | 63 |
18 Oct 15 | 295 | 14 | 136 | 44 |
24 Jul 15 | 301 | 57 | 124 | 41 |
24 Apr 15 | 292 | 58 | 124 | 42 |
23 Jan 15 | 292 | 66 | 126 | 44 |
24 Oct 14 | 288 | 63 | 124 | 44 |
25 Jul 14 | 285 | 60 | 124 | 45 |
25 Apr 14 | 282 | 55 | 121 | 45 |
24 Jan 14 | 276 | 48 | 118 | 46 |
Quality Earnings: LIVN has a large one-off loss of $202.8M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: LIVN's current net profit margins (1.9%) are higher than last year (0.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LIVN has become profitable over the past 5 years, growing earnings by 38.5% per year.
Accelerating Growth: LIVN's earnings growth over the past year (725.7%) exceeds its 5-year average (38.5% per year).
Earnings vs Industry: LIVN earnings growth over the past year (725.7%) exceeded the Medical Equipment industry 12.9%.
Return on Equity
High ROE: LIVN's Return on Equity (1.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 08:57 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LivaNova PLC is covered by 30 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Rescott | Baird |
Michael Polark | Baird |
Matt Miksic | Barclays |